603083 Cambridge Technology Operation Recommendations [Gan & Lee Pharmaceuticals: The first subject of GZR4 Phase I clinical trial in China has been administered] Gan & Lee Pharmaceutical announced that the company’s independently developed GZR4 is undergoing Phase I clinical tri

603083 Cambridge Technology Operation Recommendations

[ Ganli Pharmaceuticals : The first subject of GZR4 Phase I clinical trial in China has been administered] Ganli Pharmaceuticals announced that the company’s independently developed GZR4 is undergoing Phase I clinical trials in China, and the first patient was successfully completed recently. Subjects were dosed. GZR4 is an ultra-long-acting insulin weekly preparation being developed by Ganli Pharmaceuticals and administered once a week by subcutaneous injection. The indication is diabetes .

[ Kailuan Shares : The controlling shareholder plans to increase its holdings by no more than 2%] Kailuan Shares announced that the controlling shareholder Kailuan Group will increase its holdings of 68,500 shares of the company on September 1, accounting for 0.0043% of the total share capital, and plans to The cumulative number of shares increased in the company (including this increase in shares) shall not exceed 2% of the company's total share capital.

[ Jiu’an Medical : The suspension of free distribution of test kits in the United States will bring about commercial changes] Jiu’an Medical responded to investors on the interactive platform that the company has also noticed the policy of suspending the distribution of free test kits in the United States in September and February. The news is that the U.S. government needs to retain a certain amount of inventory to deal with the recurrence of epidemics in autumn and winter, and Congress has not approved a funding budget. As of now, the epidemic in the United States has not been effectively controlled, and stopping the free distribution of test kits will bring about business changes. In the short term, more commercial demand will be generated, and the business opportunities for the company's test kit products will increase; in the long term, changes in the epidemic in the United States will be an important factor affecting the sales of test kits.

[Guanglian Airlines: Plans to invest 300 million yuan in the construction of UAV final assembly and spare parts manufacturing project] Guanglian Airlines announced that the company plans to sign a "UAV Final Assembly and Parts Manufacturing Project Construction Agreement" with the People's Government of Gongjing District, Zigong City Book", the company plans to use the project construction area of ​​about 57,500 square meters to build a drone assembly plant and ancillary buildings, and build a new drone assembly and spare parts production line, with a total project investment of 300 million yuan.

final operation strategy: 603083 Cambridge Technology returned to to intervene near 11.31.

(This article was published at 2 a.m. on September 1, 2022 2html. The operation suggestions are for reference only and are only valid on that day)